Find uplifting stories about heroes, innovations, and solutions
85 results for "hpv"
Scientists have designed a cancer vaccine that successfully fought HPV-related throat tumors in mice, offering hope for people battling these aggressive cancers. The breakthrough lies in how the vaccine's components are arranged, making it more effective at training the immune system to recognize and destroy cancer cells.
Scientists in Mexico have successfully eliminated the virus that causes cervical cancer in patients using a groundbreaking light-based treatment. The therapy could offer new hope to millions of women worldwide who currently have limited options after HPV infection.
Nigeria is embedding the HPV vaccine into routine school health programs to prevent cervical cancer, one of the most preventable yet deadliest cancers for women. Early efforts show promise, but scaling up could save thousands of lives.
Breakthrough vaccines and treatments are dramatically reducing HPV-related cancers that affect millions worldwide. Scientists now have powerful new tools to prevent and treat cervical, throat, and other cancers caused by the virus.
Scientists have developed a therapeutic vaccine that successfully fought HPV-related cancers in mice, offering hope for patients with advanced disease. Unlike current vaccines that only prevent infection, this treatment targets existing tumors.
A groundbreaking study of 1.7 million Americans reveals that HPV vaccination slashes head and neck cancer rates by more than half in men. As smoking declines but these cancers rise, scientists have found the solution hiding in plain sight.
Nigeria's Jigawa State is protecting girls from cervical cancer with free HPV vaccines, a move that could save thousands of lives. Health officials are reassuring parents the vaccine is safe and used worldwide.
Iceland, Portugal, and Norway have reached the ambitious target of vaccinating 90% of girls against HPV by age 15, bringing cervical cancer elimination within reach. Since 2020, every European country has reported declining cervical cancer rates among vaccinated women. #
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
Scientists in China discovered that testing menstrual blood for cancer-causing HPV works just as well as traditional pelvic exams. The breakthrough could help millions who avoid screenings due to discomfort, trauma, or accessibility barriers.
African countries have prevented nearly one million cervical cancer deaths through expanded HPV vaccination programs since 2019, while new malaria vaccines are saving thousands of children across 25 nations. These historic health wins are generating $1.8 billion in economic benefits, though funding gaps now threaten to slow the momentum.
A landmark study shows South Africa's free school vaccination program slashed HPV infections by 83%, proving the vaccine works even in regions with high HIV rates. For the first time, researchers confirmed that early vaccination protects girls living with HIV just as well as those without it.
After surviving cervical cancer through expensive treatment abroad, Irakoze Gratia celebrates as Burundi launches free HPV vaccines for girls. The preventable disease kills over 1,000 Burundian women each year.
The American Cancer Society now endorses self-collected HPV tests for cervical cancer screening, removing barriers that kept many women from accessing this lifesaving care. For people who face obstacles with traditional clinic visits, this change means finally getting screened.
Women who received the HPV vaccine need far fewer cervical cancer screenings than current guidelines suggest, potentially just two or three times in their entire lives. This breakthrough could save millions of women from unnecessary medical procedures while maintaining the same health protection.
India is rolling out a nationwide HPV vaccination campaign starting February 28 to protect 14-year-old girls from cervical cancer, which kills 75,000 Indian women every year. The free vaccine will be available at 30,000 centers across the country.
A groundbreaking 18-year study from Sweden shows the HPV vaccine provides lasting protection against cervical cancer, with no signs of weakening over time. Nearly a million women participated in research that could help eliminate cervical cancer as a public health threat.
Namibia just added the lifesaving HPV vaccine to its free public health program, protecting girls from cervical cancer. Health officials are fighting misinformation while celebrating this major step toward eliminating a disease that kills too many African women.
Panama became the first country in Latin America to offer universal HPV vaccination, and it's working. Cervical cancer rates have been steadily falling since the program launched, with vaccine coverage now exceeding 85 percent.
Cervical cancer is one of the most preventable cancers, yet it claims thousands of lives each year. A safe, proven vaccine could change that story completely.
Showing 20 of 85